Jul 25 |
Why Is Gossamer Bio, Inc. (GOSS) the Best One-Dollar Stock to Buy Now?
|
Jun 25 |
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
|
Jun 25 |
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
|
Jun 24 |
Gossamer Bio a new outperform at Oppenheimer on seralutinib for PAH
|
Jun 13 |
The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street
|
Jun 7 |
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
May 14 |
Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
|
May 7 |
Gossamer Bio GAAP EPS of -$0.19 in-line
|
May 7 |
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
|
May 7 |
Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
|